Test Module 2

This letter will focus largely on WHO’s efforts to address the double challenge of malaria & COVID-19. Our work in recent months has been carried out in close collaboration with country-based experts and global partners. We are very grateful to all of our partners for their ongoing commitment and contributions.

Roles: Everyone: All Users

Regions: Chad , China, France , Italy , Rwanda , Sierra Leone , United Kingdom

Topics: Coronavirus (COVID-19), Global Health

• Nine CEPI-supported candidate vaccines are part of the COVAX initiative, with a further nine candidates under evaluation, and procurement conversations on-going with additional producers not currently receiving research and development (R&D) funding through COVAX – giving COVAX the largest and most diverse COVID-19 vaccine portfolio in the world
  
• 80 potentially self-financing countries have submitted non-binding expressions of interest to the Gavi-coor

  Roles: Everyone: All Users

  Regions: Afghanistan, Argentina, Canada , Chile, China, France , Ireland , Norway , Tonga , United Kingdom , United States , West Bank , Zambia

  Topics: Coronavirus (COVID-19), Economic Prosperity and Trade Policy, Energy, Global Health, Refugee and Humanitarian Assistance, Science, Technology, and Innovation

• Public statement for collaboration on COVID-19 vaccine development

  Roles: Everyone: All Users

  Regions: Argentina, Canada , Chad , China, Norway , United Kingdom

  Topics: Coronavirus (COVID-19), Global Health, Science, Technology, and Innovation

• Statement of the Twenty-Fourth IHR Emergency Committee

  Roles: Everyone: All Users

  Regions: Afghanistan, Angola , Chad , China, Ghana , Indonesia , Iran , Kenya , Malaysia , Mozambique , Pakistan , Somalia , United Kingdom

  Topics: Climate and Environment, Coronavirus (COVID-19), Global Health, Refugee and Humanitarian Assistance